These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19703248)

  • 1. Evolution of HIV-1 in a patient population failing multiple-drug therapy.
    Hong S; Cao J; Tu YT
    Microbiol Immunol; 2009 Sep; 53(9):535-9. PubMed ID: 19703248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.
    Ibáñez A; Clotet B; Martínez MA
    Virology; 2001 Mar; 282(1):1-5. PubMed ID: 11259184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein evolution in viral quasispecies under selective pressure: a thermodynamic and phylogenetic analysis.
    Briones C; Bastolla U
    Gene; 2005 Mar; 347(2):237-46. PubMed ID: 15725390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.
    Silva WP; Santos DE; Leal E; Brunstein A; Sucupira MC; Sabino EC; Diaz RS
    Virology; 2006 Oct; 354(1):35-47. PubMed ID: 16872654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.
    Canducci F; Sampaolo M; Marinozzi MC; Boeri E; Spagnuolo V; Galli A; Castagna A; Lazzarin A; Clementi M; Gianotti N
    AIDS; 2009 Feb; 23(4):455-60. PubMed ID: 19165083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo.
    Briones C; de Vicente A; Molina-París C; Domingo E
    Gene; 2006 Dec; 384():129-38. PubMed ID: 17059869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy.
    Frost SD; Günthard HF; Wong JK; Havlir D; Richman DD; Leigh Brown AJ
    Virology; 2001 Jun; 284(2):250-8. PubMed ID: 11384224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.
    Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Pérez-Alvarez L; Pumarola T; López-Lirola A; González-García J; Menéndez-Arias L;
    J Antimicrob Chemother; 2009 Aug; 64(2):251-8. PubMed ID: 19505892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools.
    Holguín A; Lospitao E; López M; de Arellano ER; Pena MJ; del Romero J; Martín C; Soriano V
    J Med Virol; 2008 Mar; 80(3):383-91. PubMed ID: 18205216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
    Malet I; Delelis O; Soulie C; Wirden M; Tchertanov L; Mottaz P; Peytavin G; Katlama C; Mouscadet JF; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2009 Apr; 63(4):795-804. PubMed ID: 19221102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When do minority drug-resistant HIV-1 variants have a major clinical impact?
    Heneine W
    J Infect Dis; 2010 Mar; 201(5):647-9. PubMed ID: 20102273
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
    Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
    Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of temporal structure in the short term HIV-1 evolution within asymptomatic naïve patients.
    Bello G; Casado C; García S; Rodríguez C; del Romero J; Carvajal-Rodriguez A; Posada D; López-Galíndez C
    Virology; 2007 Jun; 362(2):294-303. PubMed ID: 17275055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of raltegravir resistance during therapy.
    Sichtig N; Sierra S; Kaiser R; Däumer M; Reuter S; Schülter E; Altmann A; Fätkenheuer G; Dittmer U; Pfister H; Esser S
    J Antimicrob Chemother; 2009 Jul; 64(1):25-32. PubMed ID: 19447792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.